Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.8700+0.0500 (+2.75%)
At close: 04:00PM EDT
1.8200 -0.05 (-2.67%)
After hours: 06:39PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.48M
Enterprise value 2.17M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.30
Price/book (mrq)1.10
Enterprise value/revenue 4.63
Enterprise value/EBITDA -0.50

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 3-78.51%
S&P500 52-week change 332.65%
52-week high 311.0000
52-week low 31.3500
50-day moving average 31.9949
200-day moving average 33.7763

Share statistics

Avg vol (3-month) 338.34k
Avg vol (10-day) 322.52k
Shares outstanding 53.47M
Implied shares outstanding 63.47M
Float 82.8M
% held by insiders 13.31%
% held by institutions 122.48%
Shares short (13 Sept 2024) 4149.04k
Short ratio (13 Sept 2024) 43.18
Short % of float (13 Sept 2024) 44.36%
Short % of shares outstanding (13 Sept 2024) 44.30%
Shares short (prior month 15 Aug 2024) 4144.33k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 319 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-609.42%

Management effectiveness

Return on assets (ttm)-105.91%
Return on equity (ttm)-213.51%

Income statement

Revenue (ttm)1.2M
Revenue per share (ttm)0.47
Quarterly revenue growth (yoy)95.10%
Gross profit (ttm)N/A
EBITDA -19.01M
Net income avi to common (ttm)-19.39M
Diluted EPS (ttm)-6.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.39M
Total cash per share (mrq)1.27
Total debt (mrq)74.12k
Total debt/equity (mrq)1.26%
Current ratio (mrq)1.62
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)-13.61M
Levered free cash flow (ttm)-6.48M